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INTRODUCTION
Video endoscopy has made endoscopic diagnosis
easier. The ability to detect micro-cancer, however,
differs little between video endoscopy and fiberscopy.
Thus, no method has been established to make full
use of the video endoscope for diagnosis. If lesions
can be labeled with substances which can be detected
by video endoscope, it will be possible to establish
a new method for the diagnosis of micro-lesions,
involving computerized processing of electron sig-
nals. To establish such a method, safe labeling
substances and methods are required. We concen-
trated on indocyanine green (ICG), which emits
near-infrared rays, as a promising candidate fluo-
rescent labeling substance for use in vivo and have
succeeded in synthesizing ICG derivatives which
can bind to protein (1). If these ICG derivatives can
be labeled with antibody specific to cancer tissue, a
new method for the diagnosis of micro-lesions making
use of antigen-antibody reactions may become avail-
able. Before establishing such a method, however,
it is necessary to elucidate whether antigen-antibody
reactions take place via this method on the surface
of mucosa in vivo. We have previously developed an
infrared fluorescence imaging system, using these
labeling substances (2). Our previous study demon-
strated that ICG derivatives conjugated with existing
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antibodies to cancer-associated antigens retained
their antibody activity and fluorophotometric fea-
tures (3). The present study was undertaken to
determine whether antigen-antibody reactions would
take place on the surface of mucosa in vivo. To this
end, responses of fresh tissue specimens (biopsied
or surgically resected) to immunohistochemical
staining with anti-epithelial membrane antigen
(EMA) antibodies were examined. Furthermore,
in view of possible interference by mucus or other
factors during immunohistochemical staining of the
mucosal surface of the digestive tract, the utility of
removing mucus during pretreatment of samples
was assessed.
MATERIALS AND METHODS
Materials
Biopsied tissue specimens from 8 healthy adult
volunteers and fresh resected tissue specimens
from one patient with esophageal cancer and 4
patients with gastric cancer were stained immuno-
histochemically. Biopsy was carried out using biopsy
forceps (RADIAL JAW 3, Boston Scientific Corp.,
Massachusetts, USA), under endoscopic guidance
with a GIF-XQ200 endoscope (OLYMPUS Inc.,
Tokyo, Japan). About 2 mm in diameter mucosal
pieces of the central portion of the esophagus and
the gastric body were collected by biopsy. In patients
with cancer, approximately 1cm square pieces of
cancer-free tissue were cut out of the surgically
resected specimens of the esophagus or stomach.
Paraffin sections of normal esophagus or stomach
tissue, which had been confirmed to respond posi-
tively to immunohistochemical stain with anti-EMA
antibodies, served as controls.
Anti-EMA antibodies (mouse anti-human mono-
clonal antibodies, Code No. M 613, DAKO Co.,
Ltd., Glostrup, Denmark) were used for immuno-
histochemical staining. The color was developed with
3,3‘-Diaminobenzidine tetrahydrochloride (DAB,
DOJINDO, Co., Ltd., Kumamoto, Japan), using an
avidinbiotinylated peroxidase complex (ABC) kit
(Vector Laboratories Inc., California, USA).
Methods
Three or more non-fixed fresh tissue specimens
of each test organ were pretreated. Subsequently,
they were exposed to normal horse serum (block-
ing serum) for 15 minutes at room temperature.
The surface of each mucosal specimen was then
treated with anti-EMA antibodies under various con-
ditions and fixed in 10% formalin. Paraffin sections
were then prepared. Immunohistochemical staining
by the ABC method was performed according to the
following procedure. First, the prepared paraffin sec-
tions was exposed to biotinylated horse anti-mouse
IgG for 30 minutes at room temperature and then
to ABC for 40 minutes. This was followed by im-
mersion in DAB for 1̃5 minutes, and by color de-
velopment. Between steps, the sample was washed
with phosphate-buffered saline (PBS) solution for
5 minutes.
Pretreatment was carried out using the method
of Ida et al . (4) as follows. The method is often used
in pretreatment for endoscopic examination. Some
samples were immersed and washed in 50 ml of
water containing 20,000 U pronase (Pronase MS,
Kaken Pharmaceutical Co., Ltd., Tokyo, Japan), 1 g
NaHCO3 and 4 mg Dimethylpolysiloxane (Gascon ;
Kissei Pharmaceutical Co., Ltd., Matsumoto, Japan)
for 30 minutes at 4℃ (Group A). Other samples
were immersed in normal saline for 30 minutes
at 4℃ to prevent drying (Group B ; unpretreated
group).
After pretreatment, the non-fixed specimens of
esophageal and gastric mucosa were exposed to
anti-EMA antibodies under various sets of condi-
tions. The chromatic responses of these fresh tissue
specimens were compared according to the condi-
tions of exposure to the antibodies. The anti-EMA
antibodies used in this study were diluted at a ratio
of 1 : 25 and to pH 7.2 with PBS before use. The
following sets of conditions were employed : ex-
posure for 90 minutes at room temperature, ex-
posure overnight at 4℃, and exposure for 10, 30, 60
and 120 minutes at 37℃ with incubation (condi-
tions similar to those prevailing in vivo).
Chromatic responses were assessed as follows.
Control paraffin sections were exposed to anti-EMA
antibodies for 90 minutes at room temperature,
and the color developd by the ABC method under
conditions similar to those used for test specimens
(fresh specimens). Control sections which showed
adequate chromatic responses were rated as (+++),
those without chromatic responses as (-), and inter-
mediate degrees of chromatic responses as (++) and
(+). The chromatic responses of test specimens
were assessed by comparing them to the control
sections and they were rated on the same four-point
scale. When no sections exposed to the antibodies
under a given set of conditions showed chromatic
responses, this set of conditions was rated as (-).
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When one or two sections exposed to the antibodies
under a given set of conditions were positively
stained, the rating for the most strongly stained
section was adopted as the rating for this set of
conditions. Figure 1c and 1d shows an example
of control sections rated as (+++).
RESULTS
Chromatic responses of biopsied and resected speci-
mens to the stain under different sets of conditions
Test specimens of the esophagus and stomach
were exposed to anti-EMA antibodies under different
sets of conditions. These specimens were fixed in
formalin and paraffin sections made for color devel-
opment using the ABC method. The chromatic
responses obtained under different sets of condi-
tions are shown in Table 1.
Of the specimens without pretreatment, biopsied
esophageal specimens showed weak chromatic
responses after incubation with antibodies for 30
minutes at 37℃, but the other specimens without
pretreatment showed no chromatic responses. Of
the pretreated specimens, biopsied esophageal
specimens incubated with antibodies for 10 or 30
minutes at 37℃ showed adequate chromatic re-
sponses. However, as the reaction time was pro-
longed, transformation and destruction of tissue
took place, and no chromatic responses were seen
in pretreated biopsied esophageal specimens incu-
bated with antibodies for 60 or 120 minutes at 37℃.
Pretreated resected esophageal specimens showed
chromatic responses when incubated with anti-
bodies for 10 or 30 minutes at 37℃, but their
responses were weaker than those observed in
biopsied esophageal specimens. Of the pretreated
resected gastric specimens, those incubated with
antibodies for 60 or 120 minutes at 37℃ showed
chromatic responses, but other resected gastric
specimens when incubated with antibodies for 10 or
30 minutes at 37℃ showed no chromatic responses.
However, prereated biopsied gastric specimens
showed no chromatic responses except for the
specimens incubated with antibodies for 60 minutes
at 37℃.
Figure 2 shows chromatic responses of biopsied
esophageal specimens after 10 (Figure 2a) or 30
Fig.1. Control sections (10 x 20). a and b ; HE stained. c and d ; immunohistochemically stained with anti-EMA antibodies. a and c ;
esophageal tissue. b and d ; gastric tissue.
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Table 1. Results of Immunohistochemical Staining
Methods of Pretreatment Conditions of Exposure
Grades of Staining
Resected
specimen
Biopsied
specimen
Esophagus
A : (normal saline for 30 min. at 4℃)
exposed for 90 min. at room temp.
exposed overnight at 4℃
incubated for 10 min. at 37℃
incubated for 30 min. at 37℃
incubated for 60 min. at 37℃
incubated for 120 min. at 37℃
‐
‐
‐
‐
‐
‐
‐
‐
‐
+
‐
‐
B : (50 ml of water containing 20,000 U
pronase, 1 g NaHCO3 and 4 mg di-
methylpolysiloxane for 30 min. at
4℃)
exposed for 90 min. at room temp.
exposed overnight at 4℃
incubated for 10 min. at 37℃
incubated for 30 min. at 37℃
incubated for 60 min. at 37℃
incubated for 120 min. at 37℃
‐
‐
+ +
+
‐
‐
‐
‐
+ + +
+ +
‐
‐
Stomach
A : (normal saline for 30 min. at 4℃)
exposed for 90 min. at room temp.
exposed overnight at 4℃
incubated for 10 min. at 37℃
incubated for 30 min. at 37℃
incubated for 60 min. at 37℃
incubated for 120 min. at 37℃
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
‐
B : (50 ml of water containing 20,000 U
pronase, 1 g NaHCO3 and 4 mg di-
methylpolysiloxane for 30 min. at
4℃)
exposed for 90 min. at room temp.
exposed overnight at 4℃
incubated for 10 min. at 37℃
incubated for 30 min. at 37℃
incubated for 60 min. at 37℃
incubated for 120 min. at 37℃
‐
‐
‐
‐
+ +
+
‐
‐
‐
‐
+
‐
Fig. 2. Immunohistochemically stained views of non-fixed fresh sections (10 x 20). Epithelial cells of each specimen were stained
(see arrows). a and c ; biopsied specimen of esophagus. b and d ; resected specimen of stomach.
Incubated with anti-EMA antibodies at 37℃. a ; for 10 minutes. b ; for 60 minutes. c ; for 30 minutes. d ; for 120 minutes.
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(Figure 2c) minutes at 37℃ of incubation and
resected gastric specimens after 60 (Figure 2b) or
120 (Figure 2d) minutes at 37℃ of incubation with
antibodies. Stratified squamous epithelial cells of
the esophagus and columnar epithelial cells of fundic
glands of the stomach were positively stained in
these specimens.
Distribution of EMA in control sections and non-
fixed fresh specimens
In both control sections and non-fixed fresh speci-
mens, positive chromatic responses, as determined
using DAB as a color developer, were seen in the
cytoplasm of stratified squamous epithelial cells of
esophageal mucosa and in the cytoplasm of co-
lumnar epithelial cells of gastric mucosa. Thus,
the responses to staining with anti-EMA antibodies
were consistent between control sections (Figure
3a and 3b) and non-fixed fresh specimens (Figure
3c and 3d).
DISCUSSION
Immunohistochemical staining was first attempted
in 1941 by Coons et al., who used anthracene
isocyanate as a labeling substance (5). This staining
technique has been used primarily for paraffin or
frozen sections. At the present time, no reports of its
use in vivo (i.e ., vital immunohistochemical staining)
have been published. Since current methods of
immunohistochemical staining use toxic substances
for color development, their use in vivo presents
problems. Furthermore, since these methods involve
many reactive steps and take much time, they have
seldom been used on fresh specimens (6).
Immunohistochemical staining is based on
antigen-antibody reactions ; these phenomena usu-
ally take place in living tissue. Attempts have been
made to conjugate anti-cancer agents or products
of gene expression to antibodies which have an
affinity for lesion-specific antigens, and to adminis-
ter the conjugates to living bodies for therapeutic
purposes. These attempts have proven to some
extent effective (7, 8). In all these previous attempts,
Fig. 3. Comparison of stained areas in non-fixed fresh sections and control sections with anti-EMA antibodies (20 x 20). In fresh
sections, the cytoplasm of epithelial cells is colored brown same as in control sections (see arrows). a and b ; control sections. c and
d ; non-fixed fresh sections. a and c ; esophageal tissue. b and d ; gastric tissue.
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the conjugates were administered into blood vessels.
However, considering that antigen-antibody reac-
tions can take place throughout the living body, the
establishment of a staining method by which labeled
antibodies are administered via mucosal surfaces
is expected to lead to the development of a new
method of diagnosis and treatment. However it is
unknown whether or not the various barriers pres-
ent on mucosal surfaces suppress antigen-antibody
reactions following the administration of such anti-
bodies via the mucosa of the digestive tract.
The authors therefore examined in the present
study whether or not vital immunohistochemical
staining with antibodies administered via the mucosa
of the digestive tract would be possible. To this
end, the chromatic responses of non-fixed fresh
tissue of biopsied esophageal and gastric specimens
and resected tissue of the same organs to anti-EMA
antibodies were investigated.
Serial sections of fixed tissue specimens (contain-
ing cancer-free tissue in addition to cancerous tissue),
resected surgically from 3 patients with esophageal
cancer, 4 patients with gastric cancer and 3 patients
with colorectal cancer, were subjected to ordinary
immunohistochemical staining, using antibodies to
cytokeratin, EMA, and carcinoemborynic antigen
(CEA) which are representative immunohistochemical
markers of epithelial tumors. The chromatic re-
sponses of these sections (control sections) were
examined.
Both the cancerous and cancer-free areas of
each section were stained with anti-cytokeratin and
anti-EMA antibodies. The chromatic responses to
anti-cytokeratin antibodies were insufficient, while
those to anti-EMA antibodies were satisfactory. The
chromatic responses to anti-EMA antibodies were
particularly strong in the normal mucosal area in all
cases. Chromatic responses to anti-CEA antibodies
were observed in the cancerous area of a section
from a patient with gastric cancer and a patient with
colorectal cancer.
Because it was difficult to obtain many non-fixed
specimens from the same patient, we evaluated the
chromatic responses of specimens from different
patients to anti-EMA antibodies, because the chro-
matic responses to these antibodies did not differ
between different cases.
Anti-EMA antibodies were first reported by Ceriani
et al. as polyclonal antibodies to human milk fat
globule membranes (HMFG) (9). Later, these anti-
bodies were found to respond to a number of normal
epithelia and epithelial tumors and were called
antibodies to‘epithelial membrane antigen’. The
antigen has been partially purified, and shown to be-
long to a heterogeneous group of heavily glycosylated
proteins with a MW in the range of 265-400 kDa
(10). The antibodies used in the present study were
reported by Heyderman et al . as new monoclonal
antibodies to EMA which had higher reactivity than
did the polyclonal antibodies reported by Ceriani
et al (11). Cordell et al. reported that these anti-
bodies responded to the epithelium of normal
gastro-intestinal tract (tongue, esophagus, gastric
parietal cells, small intestine, colon, and rectum)
(12).
The chromatic responses of the mucosal epithe-
lium of the esophagus and stomach to antibodies
were analyzed in relation to the conditions under
which non-fixed fresh tissue specimens of these
organs were exposed to antibodies. Specimens of
esophageal mucosa pretreated with a mixture of
pronase and NaHCO3 showed positive responses to
the 10-minute incubation with anti-EMA antibodies,
when the ABC method was used to develop colors.
Specimens of gastric mucosa also showed chromatic
responses on incubation with antibodies for 60
minutes. As the incubation time was extended
beyond 60 minutes, chromatic responses weakened,
and transformation or destruction of mucosal tissue
occurred, making the evaluation of chromatic re-
sponses difficult. This probably indicates that since
the current method of immunohistochemical staining
involves many reactive steps and takes much time,
tissue destruction occurred during the reaction
period. Unpretreated specimens of esophagus and
stomach showed few chromatic responses, suggest-
ing that mucus affected antigen-antibody reactions
in these specimens. The time required for pretreated
specimens to show chromatic responses was shorter
for esophageal tissue than for gastric tissue. This
difference is probably due to the difference in the
structure of the two organs, i.e., probably because
the columnar epithelial cells of the gastric mucosa
are present on the narrow lumen of the fundic
glands. It is also attributable to the greater amount
of mucus produced in the stomach than in the esoph-
agus. These findings, combined with the knowledge
that the gastric mucosa is always exposed to gastric
acid, suggest that antigen-antibody reactions do not
occur in the stomach in vivo due to low pH levels, or
the antibodies administered via the gastric mucosa
undergo denaturation. The anti-EMA antibodies used
in this study had a pH of 7.2, and the PBS used as
a buffer had a pH of 7.4. The optimum pH level for
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pronase, used for pretreatment in this study, has been
reported to be between pH 6 and 8 (13, 14). It has
been reported that pronase has greater mucolytic
effects under alkaline conditions, and that the com-
bined use of pronase and NaHCO3 resulted in a
significant decrease of mucus in clinical cases (4,
15). In the present study, pronase was used in
combination with NaHCO3 for pretreatment, and it
probably manifested mucolytic effects when the pH
was over 7. The low pH level of gastric tissue seems
to interfere with the vital immunohistochemical
staining of gastric mucosa. A valid countermea-
sure against this factor is needed to establish vital
immunohistochemical staining of gastric mucosa.
When control esophageal sections were exposed
to anti-EMA antibodies, stratified squamous epithe-
lial cells showed positive chromatic reactions. When
control gastric sections were used, columnar epi-
thelial cells of fundic glands showed chromatic re-
sponses. Fresh specimens of stomach and esophagus
also showed responses similar to those observed in
control sections of the corresponding organ. These
results allow us to conclude that the chromatic re-
sponses observed in fresh sections of these organs
were an outcome of immunoreactions.
These results suggest that antigen-antibody reac-
tions can take place even on the mucosal surface
of fresh specimens if these specimens are exposed
to antibodies under optimum conditions. This means
that localization of lesions in vivo is also possible
with labeled antibodies if these antibodies are
administered under optimum conditions. However,
if the current methods of immunohistochemical
staining are used without modifications, it will be
difficult to develop a valid method of endoscopic
diagnosis making use of immunohistochemical
staining. The development of fluorescent labeling
substances which can be used safely in vivo and a
fluorescent endoscope which can detect these sub-
stances in vivo is indispensable for this purpose.
A laser fluorescent endoscope, designed to observe
the mucosal surface structure using laser-excited
fluorescence, has recently been developed. Several
reports on its use in checking for tumors of diges-
tive tract have been published (6, 16). These endo-
scopes, however, use ultraviolet rays, which are
hazardous to living tissue, for excitation. Further-
more since these endoscopes use short wavelength
regions, which involve much background noise, it
seems difficult to obtain clear images of lesions
with these endoscopes. It is therefore desirable to
develop a technique by which only lesions are excited
to emit fluorescence.
Ito et al . have developed ICG derivatives which
are excited by infrared rays to emit fluorescence.
They have also developed an imaging system for
these ICG derivatives (1, 2). The ICG derivatives
and the imaging system they developed appear to
satisfy the aforementioned requirements. Therefore,
if a fluorescent endoscope using infrared rays is
developed to catch the fluorescence emitted from
ICG derivatives in vivo, it will be possible to estab-
lish a new technique of endoscopic diagnosis on
the basis of vital immunohistochemical staining with
antibody-conjugated ICG derivatives.
Marked advances have recently been made in
medical fields, especially fields related to molecular
biology and electronic medical apparatus. It is plau-
sible to imagine that antibodies to cancer-specific
antigens will become available in the near future
thanks to further advances in molecular biology,
and that the accuracy of fluorescent endoscopy will
be improved to a level allowing the detection of very
small amounts of fluorescence-labeled antibodies.
We may expect that a method of diagnosing macro-
scopically invisible micro-cancer with the use of
antibodies to cancer-specific antigens will be estab-
lished before long.
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